Unlocking the Vitiligo Cure: This Unexpected Therapy Is Changing Lives – Here’s What You Need to Know!
Imagine waking up every day to skin that tells a story all its own—a patchwork of shades dancing across your body, not quite blending but boldly standing out. That’s life with vitiligo, a condition that’s no stranger to millions worldwide—up to 100 million, in fact. Now, here’s the kicker: despite a handful of treatments, results? They can be as unpredictable as a wild card, and no magic bullet fits all. But hold on—what if the secret lies in teamwork? A new study’s mixing an existing phototherapy treatment with an oral antioxidant supplement, and guess what? Some patients are seeing skin repigmentation climb by over 50%. Intrigued? So am I. Let’s dive into why this combo might just be the game-changer vitiligo patients have been waiting for—and what that means for the future of skincare. LEARN MORE
- Vitiligo is a condition that results in patterns of skin that look different from one another, and affects up to 100 million people worldwide.
- While treatments are available, results can vary and none will improve all cases of the autoimmune disease.
- Now, a new study that combines an existing treatment with an oral supplement is showing significant improvement in some patients.
Living with the autoimmune condition vitiligo means having unique patterns of skin that look different from the rest of your body—and more than 70 to 100 million people are affected by the condition, according to the Global Vitiligo Foundation. While some people, like model Winnie Harlow, embrace these changes, others don’t like the differences in their skin tone and though treatments for vitiligo are available, they’re imperfect and results can vary.
Now, new research suggests that a combination therapy that combines an existing treatment with an oral medication can have impressive results and improve skin repigmentation.“Vitiligo remains a challenging condition to treat,” says Giovanni Leone, MD, lead study author and a researcher at the Photodermatology and Vitiligo Treatment Center at Israelite Hospital in Rome. But this combination therapy may make it easier for patients to get the results they’re after in the future. Here’s why.
Meet the experts: Joshua Zeichner, MD, director of cosmetic and clinical research at Mount Sinai Hospital; Cindy Wassef, MD, a dermatologist at Premier Health Associates in Randolph, NJ; Giovanni Leone, MD, lead study author and a researcher at the Photodermatology and Vitiligo Treatment Center at Israelite Hospital in Rome; Pooja Sodha, MD, an associate professor of dermatology and director of the Center for Laser and Cosmetic Dermatology at the George Washington University School of Medicine & Health Sciences
What did the study find?
The randomized controlled trial, which was published in the journal Photodermatology, Photoimmunology & Photomedicine, recruited 40 patients with vitiligo and asked them to use an excimer lamp (a UV light source that’s used for phototherapy treatments in people with vitiligo) for six months. Half of those patients were also asked to take gliadin-protected superoxide dismutase (GP-SOD), an oral antioxidant supplement.
After six months, both groups had “significant improvement” in repigmentation of their skin. (Meaning, their skin had more color to it.) But those who took the antioxidant supplement along with phototherapy treatments saw a 51 percent greater improvement in their skin repigmentation. People in the supplement group also had a “superior improvement in quality of life” compared to those who just used the excimer lamp.
Why might this help?
It’s important to point out that this is a small clinical trial and that only 20 people used the combination therapy. It also involved researchers affiliated with GliSODin, which makes a GP-SOD supplement.
Still, dermatologists say there seems to be something to this.“Vitiligo is a condition where your immune system gets angry at your pigment-producing cells, leading to inflammation and blockage of pigment production,” explains Joshua Zeichner, MD, director of cosmetic and clinical research at Mount Sinai Hospital. “This clinically translates to loss of pigmentation in affected areas.”
While doctors don’t understand the exact trigger for vitiligo, it does seem to involve “significant amounts” of oxidative stress in the skin,” Dr. Zeichner says. (Oxidative stress is an imbalance of unstable and protective molecules, and often leads to cell damage.) “Phototherapy is a mainstay of treatment for vitiligo, helping to stimulate activity of the pigment-producing cells in the skin and encouraging regimentation,” Dr. Zeichner says. Gliadin is a protein that helps protect an antioxidant called superoxide dismutase as it passes through the gut, he continues. “Think of it as a fire extinguisher putting out inflammation in in the skin,” Dr. Zeichner says.
The combination treatment seems to suppress oxidative stress while allowing the skin to repigment from phototherapy, says Pooja Sodha, MD, an associate professor of dermatology and director of the Center for Laser and Cosmetic Dermatology at the George Washington University School of Medicine & Health Sciences.
Why is this needed?
Current treatments for vitiligo are “limited,” according to Cindy Wassef, MD, a dermatologist at Premier Health Associates in Randolph, NJ. Even JAK inhibitors, which are a newer vitiligo treatment that blocks certain chemical signals in the body, can only be used over no more than 10 percent of the body’s surface area, she says.
This new combination treatment “would represent a novel change to a well-understood vitiligo treatment and lead to better results,” Dr. Wassef says. Dr. Sodha agrees. “It’s one more tool in the arsenal,” she says.
There are a few things to be aware of though: People with celiac disease and a gluten sensitivity, along with those who can’t tolerate melons, shouldn’t use this treatment, Dr. Sodha says. And ultimately, more research needs to be done, she says. “We don’t have long-term data on effects of such a therapy on the effects on the body’s natural homeostasis and defenses over time,” Dr. Sodha points out. Dr. Wassef echoes that. “Most studies are small and larger controlled trials are needed to determine safety and efficacy,” she says.
What other options are available to patients now?
Patients have a lot to choose from, Dr. Sodha says. She lists off phototherapy, topical anti-inflammatory agents like topical steroids, and skin grafts, to name a few.
JAK inhibitors are the newest class of drugs used to treat vitiligo and “can be very effective in improving pigmentation, even in those who have suffered with vitiligo for a long time,” Dr. Wassef says. Patients should also make sure to use sunscreenand wear sun-protective clothes to protect their de-pigmented skin, Dr. Sodha adds.
It’s important to stress that vitiligo doesn’t need to be treated. But if you have the condition and it bothers you, talk to your dermatologist. They should be able to give you a range of potential treatment options to help.
Korin Miller is a freelance writer specializing in general wellness, sexual health and relationships, and lifestyle trends, with work appearing in Men’s Health, Women’s Health, Self, Glamour, and more. She has a master’s degree from American University, lives by the beach, and hopes to own a teacup pig and taco truck one day.




Post Comment